Cargando…

Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience

BACKGROUND. Recent studies have demonstrated improved outcomes with real‐time patient‐reported outcome questionnaires (PRO questionnaires) using questions adapted for patient use from the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE). Outside of the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Albaba, Hamzeh, Barnes, Tristan A., Veitch, Zachary, Brown, M. Catherine, Shakik, Sharara, Su, Susie, Naik, Hiten, Wang, Tian, Liang, Mindy, Perez‐Cosio, Andrea, Eng, Lawson, Mittmann, Nicole, Xu, Wei, Howell, Doris, Liu, Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853088/
https://www.ncbi.nlm.nih.gov/pubmed/31409744
http://dx.doi.org/10.1634/theoncologist.2018-0830
_version_ 1783469980632743936
author Albaba, Hamzeh
Barnes, Tristan A.
Veitch, Zachary
Brown, M. Catherine
Shakik, Sharara
Su, Susie
Naik, Hiten
Wang, Tian
Liang, Mindy
Perez‐Cosio, Andrea
Eng, Lawson
Mittmann, Nicole
Xu, Wei
Howell, Doris
Liu, Geoffrey
author_facet Albaba, Hamzeh
Barnes, Tristan A.
Veitch, Zachary
Brown, M. Catherine
Shakik, Sharara
Su, Susie
Naik, Hiten
Wang, Tian
Liang, Mindy
Perez‐Cosio, Andrea
Eng, Lawson
Mittmann, Nicole
Xu, Wei
Howell, Doris
Liu, Geoffrey
author_sort Albaba, Hamzeh
collection PubMed
description BACKGROUND. Recent studies have demonstrated improved outcomes with real‐time patient‐reported outcome questionnaires (PRO questionnaires) using questions adapted for patient use from the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE). Outside of the clinical trial setting, limited information exists on factors affecting the completion of PRO questionnaires in routine practice. The primary aim of this prospective cross‐sectional study was to evaluate patient willingness to complete PRO questionnaires on a regular basis and to better understand responder biases to improve patient feedback. MATERIALS AND METHODS. Patients performing PRO‐CTCAE toxicity and symptom PRO questionnaires in oncology clinics at Princess Margaret Cancer Centre from 2013 to 2016 were assessed for their willingness to complete PRO questionnaires using a nine‐item, tablet‐based acceptability survey. Patient‐reported characteristics (i.e., age, sex, language, marital status, education, occupation, etc.), cancer type, treatment modalities, and health metrics (i.e., Eastern Cooperative Oncology Group) were also collected. Characteristics were evaluated by logistic regression (odds ratios [OR]) using the primary outcome with prespecified levels of significance for univariate (p ≤ .10), and additional multivariate (p ≤ .05) testing. RESULTS. A total of 1,792 patients (median age 60 years; range 18–97) with various cancer diagnoses were assessed. A greater proportion of female (56%) and white (74%) respondents with an annual household income of <$100,000 (69%) participated. More than half (58%) of respondents were willing to complete PRO questionnaires at every clinic visit, and a high proportion (77%) found utility in reporting physical and emotional feelings to clinicians using PRO questionnaires. In general, patients did not find that PRO questionnaires made clinic visits more difficult (93%). In uni‐ and multivariable testing, patients were more willing to complete sleep‐ and fatigue‐related PRO questionnaires relative to chemotoxicity‐based PRO questionnaires (OR 1.52; p = .012). Patients aged 40–65 versus 18–40 years were also more likely to report high PRO questionnaire acceptability (OR 1.49; p = .025). Additional patient characteristics such as white ethnicity (OR 1.76), Canada as country of birth (OR 1.66), and English language (OR 2.15) relative to other had higher acceptability on uni‐ (p < .001) and multivariable (p < .001) analyses. Patients reporting treatment intent as palliative (OR 0.69; p = .0013) or hematological (OR 0.73; p = .027) were less likely to report high PRO questionnaire acceptability on univariable analysis; however, only palliative patients (OR 0.72) maintained this effect on multivariable testing (p = .012). Patients reporting higher health utility scores (per change in .05) also had significantly increased PRO questionnaire acceptability in uni‐ (OR 1.06; p < .001) and multivariable (OR 1.05; p = .008) analyses. No significant differences in PRO questionnaire acceptability were seen between cancer types, education level, household income, employment status, or treatment modality. CONCLUSION. Routine assessment using PRO questionnaires is associated with moderate acceptability by patients with cancer. Specific patient characteristics are associated with higher completion willingness. Additional research is necessary to identify factors associated with low acceptability of PRO questionnaires and to develop site‐, ethnicity‐, and treatment‐specific instruments to assess the value of PRO questionnaires for symptom monitoring in clinical practice. IMPLICATIONS FOR PRACTICE. This study will help to identify the clinical, demographic, and survey characteristics associated with willingness to complete patient‐reported outcome questionnaires regularly in the cancer outpatient setting.
format Online
Article
Text
id pubmed-6853088
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68530882019-11-24 Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience Albaba, Hamzeh Barnes, Tristan A. Veitch, Zachary Brown, M. Catherine Shakik, Sharara Su, Susie Naik, Hiten Wang, Tian Liang, Mindy Perez‐Cosio, Andrea Eng, Lawson Mittmann, Nicole Xu, Wei Howell, Doris Liu, Geoffrey Oncologist Symptom Management and Supportive Care BACKGROUND. Recent studies have demonstrated improved outcomes with real‐time patient‐reported outcome questionnaires (PRO questionnaires) using questions adapted for patient use from the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE). Outside of the clinical trial setting, limited information exists on factors affecting the completion of PRO questionnaires in routine practice. The primary aim of this prospective cross‐sectional study was to evaluate patient willingness to complete PRO questionnaires on a regular basis and to better understand responder biases to improve patient feedback. MATERIALS AND METHODS. Patients performing PRO‐CTCAE toxicity and symptom PRO questionnaires in oncology clinics at Princess Margaret Cancer Centre from 2013 to 2016 were assessed for their willingness to complete PRO questionnaires using a nine‐item, tablet‐based acceptability survey. Patient‐reported characteristics (i.e., age, sex, language, marital status, education, occupation, etc.), cancer type, treatment modalities, and health metrics (i.e., Eastern Cooperative Oncology Group) were also collected. Characteristics were evaluated by logistic regression (odds ratios [OR]) using the primary outcome with prespecified levels of significance for univariate (p ≤ .10), and additional multivariate (p ≤ .05) testing. RESULTS. A total of 1,792 patients (median age 60 years; range 18–97) with various cancer diagnoses were assessed. A greater proportion of female (56%) and white (74%) respondents with an annual household income of <$100,000 (69%) participated. More than half (58%) of respondents were willing to complete PRO questionnaires at every clinic visit, and a high proportion (77%) found utility in reporting physical and emotional feelings to clinicians using PRO questionnaires. In general, patients did not find that PRO questionnaires made clinic visits more difficult (93%). In uni‐ and multivariable testing, patients were more willing to complete sleep‐ and fatigue‐related PRO questionnaires relative to chemotoxicity‐based PRO questionnaires (OR 1.52; p = .012). Patients aged 40–65 versus 18–40 years were also more likely to report high PRO questionnaire acceptability (OR 1.49; p = .025). Additional patient characteristics such as white ethnicity (OR 1.76), Canada as country of birth (OR 1.66), and English language (OR 2.15) relative to other had higher acceptability on uni‐ (p < .001) and multivariable (p < .001) analyses. Patients reporting treatment intent as palliative (OR 0.69; p = .0013) or hematological (OR 0.73; p = .027) were less likely to report high PRO questionnaire acceptability on univariable analysis; however, only palliative patients (OR 0.72) maintained this effect on multivariable testing (p = .012). Patients reporting higher health utility scores (per change in .05) also had significantly increased PRO questionnaire acceptability in uni‐ (OR 1.06; p < .001) and multivariable (OR 1.05; p = .008) analyses. No significant differences in PRO questionnaire acceptability were seen between cancer types, education level, household income, employment status, or treatment modality. CONCLUSION. Routine assessment using PRO questionnaires is associated with moderate acceptability by patients with cancer. Specific patient characteristics are associated with higher completion willingness. Additional research is necessary to identify factors associated with low acceptability of PRO questionnaires and to develop site‐, ethnicity‐, and treatment‐specific instruments to assess the value of PRO questionnaires for symptom monitoring in clinical practice. IMPLICATIONS FOR PRACTICE. This study will help to identify the clinical, demographic, and survey characteristics associated with willingness to complete patient‐reported outcome questionnaires regularly in the cancer outpatient setting. John Wiley & Sons, Inc. 2019-08-13 2019-11 /pmc/articles/PMC6853088/ /pubmed/31409744 http://dx.doi.org/10.1634/theoncologist.2018-0830 Text en © 2019 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Symptom Management and Supportive Care
Albaba, Hamzeh
Barnes, Tristan A.
Veitch, Zachary
Brown, M. Catherine
Shakik, Sharara
Su, Susie
Naik, Hiten
Wang, Tian
Liang, Mindy
Perez‐Cosio, Andrea
Eng, Lawson
Mittmann, Nicole
Xu, Wei
Howell, Doris
Liu, Geoffrey
Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
title Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
title_full Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
title_fullStr Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
title_full_unstemmed Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
title_short Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
title_sort acceptability of routine evaluations using patient‐reported outcomes of common terminology criteria for adverse events and other patient‐reported symptom outcome tools in cancer outpatients: princess margaret cancer centre experience
topic Symptom Management and Supportive Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853088/
https://www.ncbi.nlm.nih.gov/pubmed/31409744
http://dx.doi.org/10.1634/theoncologist.2018-0830
work_keys_str_mv AT albabahamzeh acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT barnestristana acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT veitchzachary acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT brownmcatherine acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT shakiksharara acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT sususie acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT naikhiten acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT wangtian acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT liangmindy acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT perezcosioandrea acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT englawson acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT mittmannnicole acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT xuwei acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT howelldoris acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience
AT liugeoffrey acceptabilityofroutineevaluationsusingpatientreportedoutcomesofcommonterminologycriteriaforadverseeventsandotherpatientreportedsymptomoutcometoolsincanceroutpatientsprincessmargaretcancercentreexperience